Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ERTLäkarkonsult AB
AB
Active
Org 5594520420
Engelbrektsgatan 17 B Lgh 1202
General medical practice activities · NACE 8621
Est. 2023
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 640K
-6% vs 2024
EBITDA margin
42.5%
-33% vs 2024
Equity ratio
69.0%
Financial strength
Net profit 2025
SEK 126K
-44% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 640K
-6%
EBITDA
SEK 272K
-33%
Net profit
SEK 126K
-44%
Total assets
SEK 546K
+12%
Equity
SEK 377K
+50%
Employees
0
—
Company information
Legal name
ERTLäkarkonsult AB
Org number
5594520420
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
11 oktober 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultuppdrag som allmänläkare.
Contact
Address
Engelbrektsgatan 17 B Lgh 1202
Email
elisabeth.rosenkvist@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Helsingborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
SEK thousands
Item
2024
2025
Revenue
680
640
Staff expenses
—
—
EBITDA
403
272
Depreciation & amort.
−25
−50
EBIT
378
222
Net financials
—
1
Profit before tax
285
163
Tax
−59
−37
Net profit
226
126
Balance sheet
SEK thousands
Item
2024
2025
Total assets
487
546
Equity
251
377
Long-term debt
0
0
Short-term debt
142
16
Total debt
142
16
Financial ratios
5-year trend
EBITDA margin
42.5%
This company
15.8%
Market median
+169% vs market
2024
2025
Equity ratio
69.0%
This company
38.2%
Market median
+81% vs market
2024
2025
Return on equity
33.4%
This company
18.4%
Market median
+82% vs market
2024
2025
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
2024
2025
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
2024
2025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
EM
Emma Matilda Rosenkvist
Deputy Board Member
2023
TE
Taina Elisabeth Rosenkvist
Board of Directors
2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ERTLäkarkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Emma Matilda Rosenkvist
Deputy Board Member
0 companies
Taina Elisabeth Rosenkvist
Board of Directors
0 companies